drugset / Trial / NCT01993576

ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue.

NCT01993576

Phase 1/2 Completed 10 enrolled Jules Bordet Institute
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to determine if NIF fluoresent imaging is an effctive approch to detect the margine of the breast tumoral tissue.

Timeline

Start
2013-01
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 0.25 mg/kg Intravenous

Indications